Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Recurrence 7Lymphoma, Non-Hodgkin 6Burkitt Lymphoma 6Neoplasms, Plasma Cell 5Nausea 5Leukemia 5Vomiting 4Prostatic Neoplasms 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma 4Neoplasm Metastasis 3Lymphoma, Large B-Cell, Diffuse 3Hematologic Neoplasms 3Amyloidosis 3Smoldering Multiple Myeloma 2Oligodendroglioma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Immunoglobulin Light-chain Amyloidosis 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1

Interventions

ruxolitinib 1pegaspargase 1nelarabine 1Vincristine 1Panobinostat 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Etoposide 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Clofarabine 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, T-Cell × Calcium Dobesilate × Clear all
NCT02518750 2019-04-03

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

St. Jude Children's Research Hospital

Phase 2 Terminated
3 enrolled 6 charts
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡